Global In-vivo Imaging Market Research Report - Forecast till 2032

In-vivo Imaging Market Research Report: Information By Application (Nuclear Imaging and Optical Imaging), By Technique (Radioisotopes, Biomarkers, Luminescent Proteins Based, and Others), By End Use (Hospitals & Clinics, Imaging Center, Research Organization), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

ID: MRFR/MED/0296-HCR | 115 Pages | Author: Rahul Gotadki | February 2024         

Table of Content

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Research Objective

2.4 Assumptions

2.5 Limitations

2.6 Market Structure

2.7 Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 Porter’s Five Forces Analysis

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global In vivo Imaging Market, by Application

6.1 Introduction

6.2 Nuclear Imaging

6.2.1 PET

6.2.2 SPECT

6.2.3 Others

6.3 Optical Imaging

6.3.1 Fluorescence Imaging

6.3.2 Bioluminescence Imaging

6.3.3 Photoacoustic imaging

6.3.4 Others

7. Global In vivo Imaging Market, by Techniques

7.1 Introduction

7.2 Radioisotopes Based

7.3 Biomarkers Based

7.4 Luminescent Proteins Based

7.5 Others

8. Global In vivo Imaging Market, by End Uses

8.1 Introduction

8.2 Hospitals & Clinics

8.3 Imaging Centers

8.4 Research Organizations

8.5 Others

9. Global In vivo Imaging Market, by Region

9.1 Introduction

9.2 North America

9.2.1 U.S.

9.2.2 Canada

9.3 Europe

9.3.1 Germany

9.3.2 France

9.3.3 Italy

9.3.4 Spain

9.3.5 UK

9.3.6 Rest of Europe

9.4 Asia

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 Middle East & Africa

9.5.1 Saudi Arabia

9.5.2 UAE

9.5.3 South Africa

9.5.4 Algeria

9.5.5 Egypt

10. Competitive Landscape

11 Company Profile

11.1 Bruker

11.1.1 Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Updates

11.1.4 Key Developments

11.2 MILabs B.V.

11.2.1 Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Updates

11.2.4 Key Developments

11.3 FUJIFILM VisualSonics Inc.

11.3.1 Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Updates

11.3.4 Key Development

11.4 Mediso Ltd.

11.4.1 Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Updates

11.4.4 Key Development

11.5 LI-COR, Inc.

11.5.1 Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Updates

11.5.4 Key Developments

11.6 Aspect Imaging.

11.6.1 Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Updates

11.6.4 Key Developments

11.7 TRIFOIL IMAGING

11.7.1 Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Updates

11.7.4 Key Developments

11.8 MR Solutions

11.8.1 Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Updates

11.8.4 Key Developments

11.9 Biospace Lab S.A.

11.9.1 Overview

11.9.2 Product/Business Segment Overview

11.9.3 Financial Updates

11.9.4 Key Developments

11.10 New England Biolabs.

11.10.1 Overview

11.10.2 Product/Business Segment Overview

11.10.3 Financial Updates

11.10.4 Key Developments

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Global In vivo Imaging Market

13. Appendix

Market Segmentation


Global In-vivo Imaging Application Outlook (USD Billion, 2018-2032)




  • Nuclear imaging




  • Optical imaging




Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




  • Radioisotopes




  • Biomarker




  • Luminescent proteins based




  • Others




Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




  • Hospitals and clinics




  • Imaging centers




  • Research organizations




Global In-vivo Imaging Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • US Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Canada Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Europe Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Germany Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • France Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • UK Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Italy Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Spain Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • China Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Japan Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • India Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Australia Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Middle East Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Africa Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations






    • Latin America Outlook (USD Billion, 2018-2032)




    • Global In-vivo Imaging by Application




      • Nuclear imaging




      • Optical imaging






    • Global In-vivo Imaging Techniques Outlook (USD Billion, 2018-2032)




      • Radioisotopes




      • Biomarker




      • Luminescent proteins based




      • Others






    • Global In-vivo Imaging End-User Outlook (USD Billion, 2018-2032)




      • Hospitals and clinics




      • Imaging centers




      • Research organizations







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid